Psychemedics Stock Price, News & Analysis (NASDAQ:PMD)

$20.44 0.09 (0.44 %)
(As of 12/15/2017 04:57 AM ET)
Previous Close$20.35
Today's Range$20.14 - $20.90
52-Week Range$13.81 - $27.99
Volume19,900 shs
Average Volume36,210 shs
Market Capitalization$112.26 million
P/E Ratio18.72
Dividend Yield2.89%
Beta0.96

About Psychemedics (NASDAQ:PMD)

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

Receive PMD News and Ratings via Email

Sign-up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical & Diagnostic Laboratories
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:PMD
CUSIPN/A
Phone+1-800-6288073

Debt

Debt-to-Equity Ratio0.05%
Current Ratio2.72%
Quick Ratio2.72%

Price-To-Earnings

Trailing P/E Ratio18.72
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$38.98 million
Price / Sales2.88
Cash Flow$1.62 per share
Price / Cash12.65
Book Value$2.86 per share
Price / Book7.15

Profitability

Trailing EPS$1.11
Net Income$6.67 million
Net Margins15.06%
Return on Equity37.33%
Return on Assets24.58%

Miscellaneous

Employees206
Outstanding Shares5,490,000

Psychemedics (NASDAQ:PMD) Frequently Asked Questions

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics announced a quarterly dividend on Wednesday, October 25th. Stockholders of record on Monday, November 6th will be paid a dividend of $0.15 per share on Friday, November 17th. This represents a $0.60 annualized dividend and a dividend yield of 2.94%. The ex-dividend date is Friday, November 3rd. View Psychemedics' Dividend History.

How were Psychemedics' earnings last quarter?

Psychemedics Corp. (NASDAQ:PMD) posted its earnings results on Tuesday, October, 24th. The company reported $0.25 earnings per share (EPS) for the quarter. The company earned $10.05 million during the quarter. Psychemedics had a net margin of 15.06% and a return on equity of 37.33%. View Psychemedics' Earnings History.

When will Psychemedics make its next earnings announcement?

Psychemedics is scheduled to release their next quarterly earnings announcement on Monday, February, 5th 2018. View Earnings Estimates for Psychemedics.

Who are some of Psychemedics' key competitors?

Who are Psychemedics' key executives?

Psychemedics' management team includes the folowing people:

  • Raymond C. Kubacki Jr., Chairman of the Board, President, Chief Executive Officer (Age 71)
  • Neil L. Lerner, Vice President - Finance (Age 48)
  • Michael I. Schaffer Ph.D., Vice President - Laboratory Operations (Age 71)
  • A. Clinton Allen, Independent Director (Age 73)
  • Harry F. Connick Sr., Independent Director (Age 90)
  • Walter S. Tomenson Jr., Independent Director (Age 69)
  • Fred J. Weinert, Independent Director (Age 68)

Who owns Psychemedics stock?

Psychemedics' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Moors & Cabot Inc. (6.14%), Tieton Capital Management LLC (4.67%), Uniplan Investment Counsel Inc. (3.49%), Dimensional Fund Advisors LP (2.18%), Granite Investment Partners LLC (1.23%) and Seizert Capital Partners LLC (0.74%). Company insiders that own Psychemedics stock include Fred J Weinert, Harry F Sr Connick Sr, James V Dyke, Michael I Schaffer, Neil Lerner and Raymond C Kubacki Jr. View Institutional Ownership Trends for Psychemedics.

Who sold Psychemedics stock? Who is selling Psychemedics stock?

Psychemedics' stock was sold by a variety of institutional investors in the last quarter, including Uniplan Investment Counsel Inc., Granite Investment Partners LLC, Tieton Capital Management LLC and Carl Domino Inc. Company insiders that have sold Psychemedics company stock in the last year include James V Dyke and Michael I Schaffer. View Insider Buying and Selling for Psychemedics.

Who bought Psychemedics stock? Who is buying Psychemedics stock?

Psychemedics' stock was bought by a variety of institutional investors in the last quarter, including Quantum Capital Management, OxFORD Asset Management LLP, Moors & Cabot Inc., Dimensional Fund Advisors LP, JPMorgan Chase & Co., Bank of New York Mellon Corp and Seizert Capital Partners LLC. Company insiders that have bought Psychemedics stock in the last two years include Harry F Sr Connick Sr, Michael I Schaffer and Raymond C Kubacki Jr. View Insider Buying and Selling for Psychemedics.

How do I buy Psychemedics stock?

Shares of Psychemedics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Psychemedics' stock price today?

One share of Psychemedics stock can currently be purchased for approximately $20.44.

How big of a company is Psychemedics?

Psychemedics has a market capitalization of $112.26 million and generates $38.98 million in revenue each year. The company earns $6.67 million in net income (profit) each year or $1.11 on an earnings per share basis. Psychemedics employs 206 workers across the globe.

How can I contact Psychemedics?

Psychemedics' mailing address is 125 Nagog Park Ste 200, ACTON, MA 01720-3451, United States. The company can be reached via phone at +1-800-6288073.


MarketBeat Community Rating for Psychemedics (PMD)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about Psychemedics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Psychemedics (NASDAQ:PMD) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Psychemedics (NASDAQ:PMD) Earnings History and Estimates Chart

Earnings by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ PMD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018N/AView Earnings Details
10/24/2017Q3 2017$0.25$10.05 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.16$9.68 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.27$10.21 millionViewN/AView Earnings Details
2/10/2015Q414$0.08$0.13$6.80 millionViewN/AView Earnings Details
7/28/2014$0.03$0.16$7.69 millionViewN/AView Earnings Details
4/29/2014Q114$0.12$0.14$6.40 million$7.00 millionViewN/AView Earnings Details
2/10/2014Q4$0.16ViewN/AView Earnings Details
10/28/2013Q313$0.20ViewN/AView Earnings Details
2/25/2013Q4 2012$0.05$5.55 million$5.66 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Psychemedics (NASDAQ:PMD) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Psychemedics (NASDAQ:PMD) Dividend Information

Most Recent Dividend:11/17/2017
Annual Dividend:$0.60
Dividend Yield:2.94%
Payout Ratio:54.05% (Trailing 12 Months of Earnings)
Dividend Payments by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ:PMD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/25/2017quarterly$0.153.48%11/3/201711/6/201711/17/2017
8/3/2017quarterly$0.152.82%8/10/20178/14/20178/24/2017
4/26/2017quarterly$0.153.08%5/4/20175/8/20175/18/2017
2/6/2017Quarterly$0.152.89%2/14/20172/16/20172/27/2017
10/27/2016quarterly$0.152.62%11/3/201611/7/201611/17/2016
7/27/2016quarterly$0.153.29%8/3/20168/5/20168/15/2016
4/27/2016quarterly$0.154.15%5/4/20165/6/20165/18/2016
2/11/2016quarterly$0.155.75%2/18/20162/22/20163/4/2016
10/29/2015quarterly$0.156.01%11/5/201511/9/201511/19/2015
7/29/2015quarterly$0.155.12%8/5/20158/7/20158/18/2015
4/28/2015quarterly$0.153.71%5/6/20155/8/20155/18/2015
2/11/2015quarterly$0.153.97%2/19/20152/23/20153/6/2015
10/30/2014quarterly$0.154.17%11/6/201411/10/201411/20/2014
10/30/2014quarterly$0.1511/20/201411/10/2014
7/29/2014quarterly$0.154.22%8/5/20148/7/20148/18/2014
4/29/2014quarterly$0.153.81%5/7/20145/9/20145/19/2014
2/10/2014quarterly$0.153.8%2/19/20142/21/20143/7/2014
10/28/2013quarterly$0.154.28%11/6/201311/11/201311/22/2013
8/5/2013quarterly$0.154.68%8/13/20138/15/20138/28/2013
5/7/2013quarterly$0.155.34%5/15/20135/17/20135/30/2013
2/25/2013quarterly$0.154.98%3/5/20133/7/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

Psychemedics (NASDAQ PMD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.60%
Institutional Ownership Percentage: 57.35%
Insider Trades by Quarter for Psychemedics (NASDAQ:PMD)
Institutional Ownership by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ PMD) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/14/2017Raymond C Kubacki JrCEOBuy1,000$16.88$16,880.00View SEC Filing  
9/6/2017Michael I SchafferVPSell7,548$20.41$154,054.68View SEC Filing  
9/5/2017Michael I SchafferVPSell4,400$20.37$89,628.00View SEC Filing  
9/1/2017Michael I SchafferVPSell981$21.16$20,757.96View SEC Filing  
3/9/2017James V DykeVPSell10,513$20.56$216,147.28View SEC Filing  
12/14/2016James V DykeVPSell5,091$22.83$116,227.53View SEC Filing  
12/9/2016Fred J WeinertDirectorSell4,601$24.45$112,494.45View SEC Filing  
11/18/2016Neil LernerVPSell3,000$24.75$74,250.00View SEC Filing  
11/15/2016James V DykeVPSell10,000$23.56$235,600.00View SEC Filing  
3/2/2016Harry F Sr Connick SrDirectorBuy700$12.83$8,981.00View SEC Filing  
2/26/2016Harry F Sr Connick SrDirectorBuy1,000$12.63$12,630.00View SEC Filing  
2/24/2016Harry F Sr Connick SrDirectorBuy2,000$12.36$24,720.00View SEC Filing  
2/22/2016Harry F Sr Connick SrDirectorBuy1,000$12.61$12,610.00View SEC Filing  
2/19/2016Harry F Sr Connick SrDirectorBuy1,000$11.95$11,950.00View SEC Filing  
2/16/2016Michael I SchafferVPBuy4,507$11.09$49,982.63View SEC Filing  
12/2/2015David HodgeDirectorBuy550,000$0.01$5,500.00
11/24/2015David HodgeDirectorBuy260,000$0.01$2,600.00
9/14/2015Raymond C. Kubacki, Jr.CEOBuy2,000$10.12$20,240.00View SEC Filing  
9/10/2015Neil LernerVPBuy3,000$10.32$30,960.00View SEC Filing  
6/16/2015Michael I SchafferVPSell2,837$14.62$41,476.94View SEC Filing  
4/8/2015David HodgeDirectorBuy3,000$0.01$30.00
(Data available from 1/1/2013 forward)

Headlines

Psychemedics (NASDAQ PMD) News Headlines

Source:
DateHeadline
ETFs with exposure to Psychemedics Corp. : November 27, 2017ETFs with exposure to Psychemedics Corp. : November 27, 2017
finance.yahoo.com - November 27 at 4:33 PM
Psychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 SharesPsychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 Shares
www.americanbankingnews.com - November 15 at 10:20 AM
Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017
finance.yahoo.com - November 7 at 8:50 AM
Psychemedics Corporation (PMD) Rating Increased to Hold at BidaskClubPsychemedics Corporation (PMD) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - November 4 at 2:10 PM
ETFs with exposure to Psychemedics Corp. : October 30, 2017ETFs with exposure to Psychemedics Corp. : October 30, 2017
finance.yahoo.com - October 31 at 8:00 AM
Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?
finance.yahoo.com - October 31 at 8:00 AM
Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
finance.yahoo.com - October 27 at 10:46 AM
Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15
www.americanbankingnews.com - October 26 at 9:01 AM
Psychemedics Corporation Announces Q3 EarningsPsychemedics Corporation Announces Q3 Earnings
finance.yahoo.com - October 25 at 9:14 AM
Psychemedics Corporation (PMD) Announces  Earnings ResultsPsychemedics Corporation (PMD) Announces Earnings Results
www.americanbankingnews.com - October 24 at 8:28 PM
Psychemedics Corporation (PMD) Set to Announce Quarterly Earnings on TuesdayPsychemedics Corporation (PMD) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 17 at 5:58 AM
Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
finance.yahoo.com - October 3 at 10:52 AM
Psychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair TestPsychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair Test
www.streetinsider.com - September 27 at 11:00 PM
Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair TestPsychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
finance.yahoo.com - September 27 at 11:00 PM
Insider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of StockInsider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM
Michael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) StockMichael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 9:16 PM
Michael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) StockMichael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 8:50 PM
ETFs with exposure to Psychemedics Corp. : August 21, 2017ETFs with exposure to Psychemedics Corp. : August 21, 2017
finance.yahoo.com - August 22 at 8:29 PM
Psychemedics Corporation Launches Synthetic Cannabinoids Hair TestPsychemedics Corporation Launches Synthetic Cannabinoids Hair Test
finance.yahoo.com - August 22 at 3:27 PM
Psychemedics Corporation - First Lab Approved For Hair Testing In IowaPsychemedics Corporation - First Lab Approved For Hair Testing In Iowa
finance.yahoo.com - August 17 at 6:57 AM
Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 6:58 AM
Psychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly DividendPsychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly Dividend
www.americanbankingnews.com - August 3 at 6:20 PM
Psychemedics Corporation Announces Q2 EarningsPsychemedics Corporation Announces Q2 Earnings
finance.yahoo.com - August 3 at 7:00 AM
Psychemedics posts 2Q profitPsychemedics posts 2Q profit
finance.yahoo.com - August 3 at 7:00 AM
Psychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on MondayPsychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 10:23 AM
Psychemedics posts 1Q profitPsychemedics posts 1Q profit
marketbeat.com - April 25 at 5:52 PM
Psychemedics Corp: Its Not A ShortPsychemedics Corp: It's Not A Short
seekingalpha.com - March 27 at 9:41 AM
The Royce Funds: An Analysis Of Particularly Interesting HoldingsThe Royce Funds: An Analysis Of Particularly Interesting Holdings
seekingalpha.com - March 25 at 8:44 AM
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 24 at 7:08 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 21 at 10:54 AM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff DeadlineSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff Deadline
feeds.benzinga.com - March 15 at 9:33 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 15 at 7:27 PM
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The FirmDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The Firm
us.rd.yahoo.com - March 11 at 2:04 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 11 at 2:04 AM
PSYCHEMEDICS CORP Files SEC form 10-K, Annual ReportPSYCHEMEDICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 7 at 7:08 PM
PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmSHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - February 21 at 5:36 PM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline – PMDSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline – PMD
feeds.benzinga.com - February 17 at 9:51 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics CorporationINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation
feeds.benzinga.com - February 17 at 11:12 AM
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Psychemedics Corporation Investors and Encourages Investors to Contact the FirmGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Psychemedics Corporation Investors and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 15 at 4:36 AM
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 15 at 4:36 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation Sets Lead Plaintiff Deadline of April 3, 2017 -- PMDSHAREHOLDER ALERT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD
us.rd.yahoo.com - February 13 at 11:23 PM
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline - PMDSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline - PMD
us.rd.yahoo.com - February 11 at 1:33 AM
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff DeadlineSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - February 7 at 2:55 PM
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Psychemedics Corporation and Encourages Investors to Contact the FirmIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Psychemedics Corporation and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 6 at 7:22 PM
Psychemedics Corporation Announces Record Revenues And EarningsPsychemedics Corporation Announces Record Revenues And Earnings
us.rd.yahoo.com - February 6 at 7:22 PM

SEC Filings

Psychemedics (NASDAQ:PMD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Psychemedics (NASDAQ:PMD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Psychemedics (NASDAQ PMD) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.